Key Points
- Only one absolute contraindication: known hypersensitivity to quetiapine or any formulation excipients (anaphylaxis has been reported)
- Elderly with dementia-related psychosis: not approved for this use; associated with ~1.6–1.7x increased risk of death vs placebo (FDA boxed warning)
- QTc prolongation: avoid in congenital long QT syndrome, bradycardia, hypokalemia, hypomagnesaemia, and with concurrent QTc-prolonging drugs
- Pregnancy: limited human safety data; neonatal withdrawal symptoms reported; use only if benefit clearly outweighs risk
- Breastfeeding: not recommended
Absolute Contraindication
- Hypersensitivity to quetiapine or any excipient in the formulation; anaphylactic reactions have been reported

